Nelson Obus' portfolio
In the Q2 2026 13F, filed August 14, 2026, Wynnefield Capital reported 8 US stock positions worth $145M. The largest was Natures Sunshine Products (NATR) at 37.1% of the portfolio. Added to: Cadre (CDRE). The Q3 2026 13F is due by November 14, 2026.
What changed in Q2 2026
Compared with the previous 13F. Values are as reported at quarter end. How to read a 13F.
Holdings
8 US-listed positions in the Q2 2026 13F, largest first.
| Stock | % of portfolio | Value | Shares | Last quarter |
|---|---|---|---|---|
| Natures Sunshine ProductsNATR | 37.09% | $54M | 2,473,686 | Held |
| CadreCDRE | 23.63% | $34M | 1,205,000 | Added |
| Lifecore Biomedical | 16.98% | $25M | 4,703,216 | Held |
| DLH HoldingsDLHC | 13.29% | $19M | 3,681,421 | Held |
| Agnico Eagle MinesAEM | 3.73% | $5M | 35,000 | Held |
| Quest Resource HoldingQRHC | 2.37% | $3M | 2,734,349 | Held |
| TechprecisionTPCS | 1.56% | $2M | 433,605 | Held |
| SILSIL | 1.33% | $2M | 25,000 | Held |
By sector
Share of the reported value.
Reported value over time
Total 13F value at each quarter end.
Questions
What stocks does Nelson Obus own?
In the Q2 2026 13F, Wynnefield Capital reported 8 US stock positions worth $145M. The largest: Natures Sunshine Products (NATR) 37.1%, Cadre (CDRE) 23.6%, Lifecore Biomedical 17.0%, DLH Holdings (DLHC) 13.3%, Agnico Eagle Mines (AEM) 3.7%.
What did Nelson Obus buy last quarter?
In Q2 2026: added to Cadre (CDRE).
When is Nelson Obus's next 13F?
13F filings are due 45 days after each quarter ends. The Q3 2026 filing is due by November 14, 2026.
More investors
13F filings list US-listed long positions (and some options) held at quarter end. They leave out short positions, cash,
bonds and non-US holdings, and arrive up to 45 days after the quarter ends, so the investor may have traded since. Information only, not investment advice.
Photo: http://nelsonobus.com/ (credits).